We present a new stochastic model for genotype generation. The model offers a compromise between rigid block structure and no structure altogether: It reflects a general blocky structure of haplotypes, but also allows for "exchange" of haplotypes at nonboundary SNP sites; it also accommodates rare haplotypes and mutations. We use a hidden Markov model and infer its parameters by an expectation-maximization algorithm. The algorithm was implemented in a software package called HINT (haplotype inference tool) and tested on 58 datasets of genotypes. To evaluate the utility of the model in association studies, we used biological human data to create a simple disease association search scenario. When comparing HINT to three other models, HINT predicted association most accurately.
INTRODUCTION M
ost variation in the DNA sequence among individuals is at specific positions, where more than one nucleic acid can be observed across the population. These positions are called single nucleotide polymorphisms (SNPs) (Patil et al., 2001; Gabriel et al., 2002) . In almost all cases only two alternative bases (alleles) occur at a SNP site. The total number of common human SNPs is estimated to be about 10 million (Kruglyak and Nickerson, 2001; Botstein and Risch, 2003) . The sequence of alleles in contiguous SNP sites along a chromosomal region is called a haplotype. Identification of haplotypes is a central challenge of the HapMap project (www.hapmap.org), due to their expected importance in disease associations (Martin et al., 2000; Morris and Kaplan, 2002) .
Diploid organisms, like human, have two homologous (nearly identical) copies of each chromosome (except the sex chromosome). Most experimental techniques for determining SNPs do not provide the haplotype information separately for each of the two chromosomes. Instead, they generate for each site an unordered pair of allele readings, one from each copy of the chromosome (cf. Sachidanandam et al. [2001] ). The sequence of these pairs is called a genotype. A homozygous site in the genotype of an individual has two identical bases, while a heterozygous site has different bases on the two chromosomal copies at that site. The process of inferring the haplotypes from the genotypes is called phasing or resolving. Without additional information, each genotype with h heterozygous sites in a population can be resolved in 2 h−1 different ways. Thus, one must use some model of how the haplotypes are generated in order to perform genotype resolving. Since Clark's introduction of the problem in 1990 (Clark, 1990) , many studies School of Computer Science, Tel-Aviv University, Tel-Aviv 69978, Israel.
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attempted to solve it (Excoffier and Slatkin, 1995; Long et al., 1995; Stephens et al., 2001; Stephens and Donnelly, 2003; Niu et al., 2002; Gusfield, 2002; Eskin et al., 2003; Greenspan and Geiger, 2003; . These studies suggested a variety of models and proposed methods to simultaneously phase a set of genotypes under the model's assumptions.
Several researchers observed that haplotypes tend to be preserved along relatively long genomic stretches, with recombination occurring mostly in narrow regions (Gabriel et al., 2002; Patil et al., 2001) . The stretch of SNP sites between two neighboring recombination regions is called a block. The number of different haplotypes within each block that are observed in a population is very small: typically, some 70-90% of the haplotypes within a block are identical (or almost identical) to very few (2-5) distinct common haplotypes (Patil et al., 2001) . Several studies suggested algorithms for the block identification and partitioning in a given dataset of haplotypes (e.g., Zhang et al. [2002a Zhang et al. [ , 2003 ; Koivisto et al. [2003] ; ). Recently, several studies proposed algorithms for simultaneous block partitioning and phasing on genotype data (Greenspan and Geiger, 2003; Kimmel and Shamir, 2005) . However, as block patterns are sometimes unclear, it has been argued that less restrictive models of haplotype generation are needed (e.g., Wall and Pritchard [2003] ; Bafna et al. [2003] ).
In this study, we provide a new stochastic model for genotypes generation. The model, which generalizes our previous rigid blocks model , aims to reflect two complementary (and somewhat contradictory) features observed on real haplotypes datasets: On one hand, contiguous SNPs tend to form "blocks" in which the recombination rate is low and with few distinct haplotypes. On the other hand, that block structure is not always conserved: Recombination may occur outside block boundaries, and some haplotypes may not fit the general structure altogether. From a different viewpoint, it was observed that different positions have different probability of recombination, and the linkage disequilibrium (i.e., the correlation between allele occurrence at different sites) is higher in some block-like regions than in others (Wall and Pritchard, 2003) . The model preserves a basic "blocky" structure of haplotypes, but also allows for "exchange" of haplotypes at every point, and not only at block boundaries. Thus, it is possible that a specific contiguous stretch of SNPs identified as part of a haplotype can start or end inside another block of SNPs. Additionally, in any interval, some of the haplotypes may not be part of the blocky structure. We show how to infer the parameters of the model by deriving an EM method to achieve a maximum likelihood phasing solution.
We implemented our algorithm in a program called HINT (haplotype inference tool), which includes also a simple procedure to predict disease association. We tested HINT on 58 human datasets from four sources: HapMap project (www.hapmap.org), ENCODE project (www.hapmap.org), Daly et al. (2001) , and Gabriel et al. (2002) . Our experiments show that our algorithm consistently outperforms a strict blocks model and is also significantly more accurate than using haplotypes or using the raw genotypes.
We would like to point out that haplotype phasing is not strictly necessary for association testing. One can test for association of unphased genotypes, and the utility of using haplotypes is under debate (Morris and Kaplan, 2002; Martin et al., 2000; Zhao et al., 2003; Zaykin et al., 2002; Zhang et al., 2004) . As we shall show, in our tests more accurate results are achieved by using our model than by using the raw genotypes.
The paper is organized as follows: In Section 2, we present the stochastic model. In Section 3, we show how to infer the parameters of the model. In Section 4, we present the experimental results. Section 5 discusses our methodology and future directions.
THE STOCHASTIC MODEL
The input to our problem is presented by an n × m genotype matrix M in which the rows correspond to samples (individuals genotyped) and the columns correspond to SNP sites. Hence, the i-th row M[i, * ], also denoted by g i , describes the i-th genotype (the vector of readings for all the SNP sites in the ith individual). We assume that all sites are bi-allelic and that the two alleles are called arbitrarily 0 and 1. The genotype readings are denoted by M[i, j ] ∈ {0, 1, 2, ?} where 0 and 1 stand for the two homozygous types {0,0} and {1,1}, respectively, 2 stands for a heterozygous type, and "?" stands for a missing entry. A phasing of genotype g i is a pair of binary n-vectors i,j to denote the j th component (0, 1, 2, or ?) of the vector g i . Given a genotype matrix, the phasing problem is to determine the most likely n pairs of haplotype vectors that constitute phasing of the corresponding genotype vectors. "Most likely" must be defined with respect to an assumed data model.
We now describe our probabilistic model for how the genotypes are generated. The model relaxes the rigid block structure assumption and allows for recombination of haplotypes at every point, and not only at block boundaries. Thus, it is possible that a specific contiguous stretch of SNPs starts or ends inside another block of SNPs. Additionally, in any interval, some of the haplotypes may not be part of the blocky structure. In a nutshell, the model is a hidden Markov model with few possible states at each site, each with its own emission probability, allowing transition from any state to any state in the next site. For each site there are at most k alternative states. Each genotype is created as the confluence of two independent Markov paths, each creating a single haplotype. Figure 1 gives an example of the model when applied on chromosome 5 dataset .
We now define the model formally. The model has a position for each SNP site, and we use the terms site and position interchangeably. At each position there are k states. We denote by S i,j the ith state in the j th position. Each state generates ("emits") a SNP value in its corresponding position. We denote by θ i,j the probability to generate "1" in the j -th site of the i-th state. (Consequently, 1 − θ i,j is the probability to generate "0" in that site.) Let α (q) denote the transition probability matrix from states in position q to states in position q + 1. Transition probabilities between nonconsecutive positions are zero. The components of α (q) are denoted by (α (q) 
The starting state is denoted by S 0 , and its corresponding transition probabilities to {S i,1 } 1≤i≤k are denoted by α (0) 1,i . Each genotype in the matrix M is generated as follows: For each haplotype independently, start from state S 0 and choose a number i between 1 and k according to the probability distribution {α
Pass to state S i,1 and choose the first SNP value to be 1 with probability θ i,1 . When at state S i,q , choose a number j between 1 and k according to the probability distribution {α
and choose the (q + 1)th SNP value to be 1 with probability θ j,q+1 . Continue the path until reaching one of the states {S i,m } 1≤i≤k (all m SNP values have been generated). Repeat the steps above for the second haplotype and form the confluence of the two haplotypes . The result is the genotype.
We now develop the likelihood function under the model. Define f (g i,j ; θ a , θ b ) to be the probability of the observed value of the j th SNP in the ith genotype, given that the probabilities to observe 1 in the two paths that created the genotype are θ a , θ b , respectively. Then
denote the state number of the first and second paths, respectively, of the ith genotype in the j th position. Note that I (0) i = 1 and J (0) i = 1 for 1 ≤ i ≤ n. We use θ and α to denote the sets {θ i,j : 1 ≤ i ≤ n, 1 ≤ j ≤ m} and {α (j ) : 0 ≤ j ≤ m − 1}, respectively. The full set of parameters is denoted by ϑ := θ ∪ α. The complete likelihood function can be written as follows:
The complete log likelihood function is
) .
(
Dealing with missing entries is done as follows: given a missing entry, we sum over all possible values of the entry (0, 1, and 2), since these events are mutually exclusive. Inspection of Equation (1) reveals that this is equivalent to using a probability of 1 for the missing entry. In this way, missing entries are treated as part of the model and need not be handled separately from the optimization procedure.
FIG. 1.
A graphical illustration of the probabilistic model, obtained on the data of Daly et al. (2001) data. Each node is labeled by the name of the nucleotide that is more likely to be emitted at the corresponding state (i.e., the nucleotide in state i of position j is that corresponding to 1 if and only if θ i,j > 0.5). Transitions between states in consecutive positions are represented by edges with edge thickness proportional to probability of transition. For readability, only edges with probability above 0.05 are shown. Node probabilities are calculated from the Markov chain model and color coded according to the legend. The top line contains the SNP numbers. The picture was generated using the software Graphviz (www.research.att.com/sw/tools/graphviz). Observe that certain stretches of sites manifest a block-like structure, with little or no transition between lines of states (e.g., 1-6, 7-9, 10-14, 29-31, 61-64) . Other stretches (e.g., 15-20, 38-44) contain many crossings and show little block structure.
AN ALGORITHM FOR INFERRING THE MODEL PARAMETERS
Using the maximum likelihood approach, the goal is to find a set of parameters ϑ that maximizes (1).
: ∀i, j } are unknown, we use EM approach (e.g., McLachlan and Krishnan [1997] to be 1 if A (j ) a,b,i = 2, and 0 otherwise. Now, Equation (1) can be rewritten as:
Taking the expectation with respect to the probability measure under the parameter set ϑ 0 , we get
For compactness of writing, we use matrices to describe the above equations. Define the matrices W
If U, V are n×m real matrices, let U •V denote the inner product of the two matrices: U •V = trace(U T V ) (equivalently, it can also be expressed as
. We use U a,· to denote the ath row of U , and U ·,b to denote the bth column of U . Vector e n e n e n is defined to be the vector (1, 1, . . . , 1) T of size n. Let S n denote the n-dimensional open simplex, i.e., S n = {x ∈ R n | ∀i : 0 < x i < 1}.
Using the above definitions, Q M,ϑ 0 (ϑ) can be rewritten, and we get the following optimization problem:
We use the interior domain of the simplex, excluding the surface, since we want the objective function to be twice continuously differentiable. For practical purposes, this assumption is not significant. We use W, Y, α, G to denote the sets {W
}, respectively. Note that W, Y are constants and α, G are determined directly by the parameters set ϑ. The constants W, Y are obtained using ϑ 0 , as will be presented below. The optimization problem (3) is called "the genotypes optimization subproblem." Clearly, a solution ϑ to the genotypes optimization subproblem increases the complete likelihood score of (1).
We now describe the expectation and maximization steps of the algorithm. We show how to calculate W and Y given ϑ and how to calculate ϑ when W and Y are known. We also explain how we resolve the genotypes, once the model's parameters are found.
Expectation
Since each genotype is generated by two passes through the hidden Markov model, we can formally double the model for the representation below. In this doubled model, for each position there are k 2 states, which correspond to all possible pairs of states in the original model. We denote them by {D {a,b},j : 1 ≤ a ≤ b ≤ k, 1 ≤ j ≤ m}, where D {a,b},j corresponds to the pair of states S a,j , S b,j . Let Pr[e|D {a,b},j ] denote the probability to observe e ∈ {0, 1, 2}, given the state D {a,b},j . The probability to obtain 0, 1, and 2 in each of these states can be calculated as follows:
The transition probabilities in the doubled model can also be calculated directly:
Using the Baum-Welch algorithm (Baum, 1972) , we find Pr[D {a,b},j , D {c,d},j +1 |g i ], and we can then obtain
We are now ready to calculate the expectation:
Now, matrices W
can be obtained by substituting (4) into (2).
Maximization
The following lemma implies that solving the genotypes optimization subproblem, even when W and Y are given, is not trivial, as the optimization function is neither convex nor concave.
Lemma 1. The genotypes optimization subproblem is neither convex nor concave.
Proof. It suffices to give an example where convexity and concavity do not hold. Let k = 2 and m = 2. The function Q M,ϑ 0 (ϑ) is assumed to be twice continuously differentiable, and thus we use H (ϑ) to denote the Hessian matrix of Q M,ϑ 0 (ϑ) at point ϑ. We note that Q M,ϑ 0 (ϑ) is the sum of functions of α (0) , α (1) , θ ·,1 , and θ ·,2 , and hence it is enough to show that Q M,ϑ 0 (ϑ) is nonconvex and nonconcave in θ ·,2 . Denote by H (θ ·,2 ) the submatrix of H (ϑ), which is induced only by θ ·,2 ; i.e., (H (θ ·,2 )) i,j :=
. We can write Q M,ϑ 0 (ϑ) as follows: and on the genotypes data. In this way, the Hessian matrix is Choosing θ ·,2 = θ ·,2 = (0.5 0.5) T , we get
We can set R to be larger enough than P 11 , S 11 , P 22 , S 22 , such that det[H ( θ ·,2 )] < 0. This is possible since the constants P 11 , S 11 , P 22 , S 22 depend only on the number of homozygous SNPs (0 or 1) and R depends only on the number the heterozygous SNPs (2). According to the Frobenius Theorem, since all the components of (5) are negative, it has at least one negative eigenvalue, and since det[H ( θ ·,2 )] < 0, the other eigenvalue must be positive. If the signs of the two eigenvalues of
is neither positive semi-definite nor negative semi-definite, so θ ·,2 is a feasible point, where the function Q M,ϑ 0 (ϑ) is nonconvex and nonconcave.
Notice that if the haplotypes are given in a resolved form, and the problem is only to find the parameters, then we have a simple hidden Markov chain model. In this case, the optimization subproblem is convex and has an analytical solution using the Baum-Welch algorithm (Baum, 1972) . In general, the whole EM process converges to a local optimum that is not necessarily the global optimum, but as we shall show, overall performance is usually good and robust on the real data that we used.
A solution to the genotype optimization subproblem. Although, as was shown in Lemma 1, the genotype optimization subproblem is nonconvex and nonconcave, we cope with it in the following way: As can be observed in (3) the function Q M,ϑ 0 (ϑ) is a linear combination of log(α (j ) ) and log(G (j +1) i ), for all 0 ≤ j ≤ m − 1. Thus, we can perform the optimization process for each j separately. For a given j , we want to solve
Under the domain ϑ j ∈ S |ϑ j | , the Lagrangian is
where λ = (λ 1 , . . . , λ k ) T ∈ R k . We find an analytical solution for α (j ) by solving
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Finding θ j is done numerically by solving
which is neither convex nor concave, by Lemma 1. However, we note that there are only k variables in this optimization problem, and k is assumed to be small, so solving it numerically is possible in practice. Moreover, when working with biological genotypes, it is reasonable to restrict the possible values of θ j to be close to 0 or close to 1. Hence, we solve the same optimization problem described in (8), but we use the domain S n = {x ∈ R n | ∀i : 0 < x i < or 1 − < x i < 1} instead of S n , where is some small constant.
Resolving the genotypes
Once the parameters set ϑ = { α, θ} is found, we use Viterbi's algorithm (Viterbi, 1967) to find the optimal path for each genotype in the double Markov chain model. The algorithm provides a pair D {a 1 ,a 2 },j for each position j , and one still has to determine the two paths corresponding to the two haplotypes, in terms of the original Markov chain. If for a genotype g i , in positions j, j + 1, the two state pairs found by the algorithm are D (a 1 ,a 2 ),j and D (b 1 ,b 2 ),j +1 , respectively, then we have two possibilities for the two paths in the original Markov chain:
For each, the probability can be calculated as follows:
We choose the possibility with larger probability, and thus the resulting two paths maximize the likelihood as required. Once we have a separate path for each haplotype, we resolve each SNP in each haplotype, according to the larger probability in each site. If for haplotype h i,p (where p ∈ {1, 2}) in position j the corresponding state is S a,j , then h i,p,j is determined to be 0 if θ a,j < 0.5, and 1 otherwise.
RESULTS ON BIOLOGICAL DATASETS
We implemented our algorithm in a software package call HINT (haplotype inference tool). HINT was implemented in C++. Running time on a 2 GHz Pentium 4 for 100 genotypes with 100 SNPs is approximately two minutes.
Description of the datasets
We tested HINT extensively using four datasets encompassing 58 different genomic regions.
• A dataset due to Daly et al. (2001) . In this study, genotypes for 103 SNPs from a 500 KB region of chromosome 5q31 were collected from 129 mother, father, and child trios from a European derived population in an attempt to identify a genetic risk for Crohn's disease. We used only the child population in this dataset.
• Population D from the study of Gabriel et al. (2002) . The data consist of 51 sets of genotypes from various genomic regions, where the number of SNPs per region ranges from 13 to 114.
• Regions ENm013, ENr112, and ENr113 of the ENCODE project (www.hapmap.org). These are 500 KB regions of chromosomes 7q21.13, 2p16.3, and 4q26, respectively, which were collected from 30 trios. The numbers of SNPs genotyped in each region are 361, 412, and 515 respectively (thus, the density of the sample is 3-5 times greater than the density of that of Daly et al. [2001] ). For convenience, we divided each of these regions into four or five datasets that contain approximately 100 SNPs each.
• Genotypes from the HapMap project (www.hapmap.org). We used three sets of SNPs spanning the three genes PP2R4, STEAP, and TRPM8. For each of these genes, we took the HapMap SNPs that are spanned by the gene plus 10 KB upstream and downstream. The resulting sets contain 39, 23, and 102 SNPs.
The last three sets contained 30 mother, father, and child trios from Yoruba's population. In each case we used only the 60 genotypes of the parents.
Initialization and predefined constants
When using the model to predict diseases, we chose to use k = 5 on all datasets since our tests show that this value obtains the most accurate results on a large number of different datasets (Fig. 2) . Here, we used mean prediction rate as a measure for accuracy. This measure reflects the accuracy in predicting a missing causative SNP and will be described in detail in Section 4.4. Notably, the changes are minor when different values of k are used.
We used the GERBIL software for finding initial parameter values for HINT. GERBIL phases the data and creates a block partition. In each block, the number of common haployptes in GERBIL is determined using a minimum description length criterion (see Section 4.3). We use only the k most common haplotypes in each block, where k is a predefined parameter of HINT. A probability matrix is computed for the transitions between common haployptes in consecutive blocks. Accordingly, if the neighboring SNPs j and j + 1 are in the same block, then the initialized values of α (j ) are set to be α α (j ) is set according GERBIL's transition probability matrix between common haplotypes. Each parameter θ is initialized to its corresponding value in GERBIL.
MDL comparison
In order to assess the possible advantage of our new block-free model over a rigid block model, we chose to compare it to GERBIL. This choice was made due to two reasons: first, GERBIL was shown to be relatively accurate , and second, the main difference between the two models is the strict block structure of GERBIL. Since the HINT model is more complex, direct comparison of likelihood is meaningless. Instead, we calculated the minimum description length (MDL) score in both solutions, as suggested by Greenspan and Geiger (2003) and by Koivisto et al. (2003) using the formula: Length(Model, Data) = Length(Model) + Length(Data | Model), where Length(·) measures the description length in bits. We used accuracy of (log n)/2 to describe the numbers, based on (Rissanen, 1987) . Hence, Length(Model) is the length of the parameters in bits, and Length(Data | Model) = − log(Pr[Data | Model]) = −l(M), which is derived in Equation (1).
Our experiments show that using k = 2 achieves the minimal MDL score, so we used this value for the MDL evaluation. The results on all datasets are presented in Fig. 3 . For GERBIL's model, the parameter k and the blocks partition are chosen to minimize the MDL score. HINT's MDL score was significantly lower than GERBIL's with paired t-test p-value of 0.0074. The mean of the difference between HINT's MDL score and GERBIL's score was 695.58. We would like to comment that using k = 2 in HINT is not the optimal parameter for disease prediction (see Section 4.2), although it is the optimized parameter for the MDL score.
Disease Prediction
We wanted to assess the model's utility in another test, which is paramount for medical applications: the veracity of predicting genotypes at unobserved SNPs. This is a first step towards finding disease alleles. For that purpose, we used real genotypes to simulate case-control data, as follows: Suppose a single SNP causes the disease with 100% penetrance. Assume that the SNP value (0, 1, or 2) is the phenotype data. Our test is done in a leave-one-out manner: We select one test genotype and use the rest as training data. In all genotypes, the causative SNP is removed. In the training data, its value is used as the phenotype of each genotype. The goal is to determine the phenotype of the test genotype, based on the training information and on the other SNPs in the test genotype. The process is applied repeatedly by selecting all possible combinations of test genotype and causative SNPs.
Formally, for a genotype matrix M, let s be the test genotype number, and let t be the missing SNP number. For specific s, t, we build the n − 1 × m − 1 induced matrix M s,t , which equals M without the tth line and the sth column: T be the missing SNP vector in the training set genotypes, and let g s,t = (M s,j : j = t) be the test genotype without that SNP. The goal is to predict the causative SNP based on the training data. Let Pred be an algorithm that predicts the phenotype in a test genotype given training data (genotypes and phenotypes). Let Pred(M s,t , d s,t , g s,t ) be the value predicted by Pred for the tth SNP in the sth genotype. Note that the input for the learning algorithm does not include the position of the missing SNP (t). The prediction accuracy µ is the probability to be correct in predicting a specific SNP in some genotype and is evaluated by (see Halperin et al. [2005] ):
We checked two different scenarios:
1. The phenotype value is given as the original form of the missing SNP (0, 1, or 2). The goal here is predict that value. 2. A dominant disease model is assumed, where values of 1 or 2 in the causative SNP represent cases and 0 represents controls. The phenotype information is represented only in the form of case/control (both as an input for the prediction algorithm and as the predicted value).
In both models, we assume 100% penetrance, which is unrealistic. The reason is that we wish to measure the disease prediction accuracy of several models. Adding randomness by using lower penetrance may reflect the biological reality better, but would have obfuscated this measured value.
We now present our prediction algorithm. The algorithm, a variation of the prediction algorithm of Halperin et al. (2005) , is based on the observation, made by several biological studies, that the correlation between SNPs tends to decay as the physical distance increases (see, e.g., Gabriel et al. [2002] ; Bafna et al. [2003] ; Daly et al. [2001] ; ; Halperin et al. [2005] ). We assume that given the genotypes values of two SNPs, the probabilities of the values at any intermediate SNPs do not change by knowing the values of additional more distant ones. This assumption, although not valid in all cases, was shown to lead to accurate results in predicting SNPs correctly (Halperin et al., 2005) . Here, we apply some variation of the algorithm described by Halperin et al. (2005) to predict the missing SNP in two steps: (1) finding two consecutive SNPs j, j + 1 in the training set that predict the phenotype most accurately and (2) predicting the missing SNPs using SNPs j, j + 1. The prediction algorithm is presented in Fig. 4 . For simplicity, we describe scenario (1), where the SNP value itself (0, 1, or 2) is the phenotype.
We compared the prediction accuracy of HINT to that of three different models: resolved haplotypes, genotypes, and a strict blocks model. For each of the four methods, we first constructed an axillary matrix A FIG. 4 . The prediction algorithm. using the specific model. Then, using M = A, the same prediction algorithm described above (Fig. 4) was employed in the four cases to predict the disease status or the missing SNP of the test genotype. The matrix A reflects the data and the additional information obtained by the model. It is calculated as follows:
1. For the HINT model, A is a 2n × m matrix that contains the states' indices of the resolved haplotypes of the data. Hence, if the SNP g i (j ) was found using HINT to be generated by states (S q 1 ,j , S q 2 ,j ), then (A) 2i−1,j = q 1 and (A) 2i,j = q 2 . (Hence, A i,j ∈ {1, 2, . . . , k}.) 2. For the haplotypes model, A is a 2n×m matrix that equals the resolved haplotype matrix of the genotype matrix M. (Hence, A i,j ∈ {0, 1}.) Here the true haplotypes information available from pedigree data was used. 3. For the simple SNPs model, A is a n × m matrix that equals the genotype matrix M. (Hence, A i,j ∈ {0, 1, 2}.) 4. For a strict blocks model, we use GERBIL Tables 1 and 2 . HINT shows a consistent advantage over the other models on most data sets. Notably, the simple haplotypes model was the second most accurate. The differences between the different models are statistically significant. For example, in the SNP prediction model, the difference between the HINT model and the haplotypes model is 7.4 STDs, which corresponds to a t-test p-value of 6.15 · 10 −12 . A less significant difference is seen in the heterozygous disease model, possibly due to loss of information (p-value = 0.039). Interestingly, in both SNP and disease prediction scenarios, the blocks structure model was the least accurate.
FIG. 5
. SNP value prediction rates for all the biological datasets: black X-HINT, red circles-haplotypes, blue +-genotypes, green triangles-strict blocks (GERBIL). Datasets 52-69 from the ENCONDE project have high density SNPs, which explains the better prediction rate by all the algorithms.
FIG. 6.
Disease phenotype prediction rates for all the biological datasets: black X-HINT, red circles-haplotypes, blue +-genotypes, green triangles-strict blocks (GERBIL). 
DISCUSSION
In this paper, we have defined a novel model for genotypes generation. The model aims to reflect the somewhat blocky structure of haplotypes, but allows deviations, i.e., intrablock transitions. A first-order Markov model is kept, without the need to maintain a strict block structure. We have shown how to resolve the model parameters using an EM algorithm.
Our model was examined on a broad spectrum of biological datasets. The prediction rate was used as a measure for the validity of the model. The goal in our experiments was to predict a missing causative SNP, given a training set of genotypes. We have shown that HINT gives more accurate results when compared to simpler models. The advantage is not very large, but is statistically significant. An additional interesting byproduct of our analysis is the conclusion that better predictions are made when using haplotypes compared to using genotypes. The strict blocky structure, on the other hand, seemed to cause loss of information and was less accurate in predicting diseases.
It has been argued that haplotype block structures can be helpful for association studies because each haplotype block can be treated as a single locus with several alleles (the block-specific haplotypes) . It was shown that finding the blocks of SNPs is expected to contribute to association studies, by decreasing the number of SNPs needed to be genotyped, with minimal statistical power loss (Zhang et al., 2002b) . A major problem is that, currently, there are different ways of defining and identifying haplotype blocks (for example, Kimmel et al. [2003] ; Zhang et al. [2002a] ; Koivisto et al. [2003] ). The advantage of blocks is in reducing the number of multiple tests one has to perform, when conducting association studies. Nevertheless, this approach has a drawback, the information loss. Here, we try to take some advantage of the blocks, and by relaxing the model to a "mosaic-like" structure, less information is lost. We plan to explore the power of HINT in disease association studies.
Another interesting question is whether using a higher-order Markov model improves the accuracy. Biologically, an improvement is expected as there is evidence for SNPs that are more linked to distal ones than to closer SNPs (Carlson et al., 2004) . On the other hand, adding more parameters to the model is a major disadvantage, as the extent of data we have is limited and the learning process may become infeasible.
A natural alternative to the hidden Markov model is a recombination-based approach, which attempts to reconstruct the past recombination events in the gene genealogy rather than seek ad hoc exchanges of extant haplotypes. The method presented here is much faster, while most investigators that have attempted the ancestral recombination graph (ARG) reconstruction approach have found it to be prohibitively slow (Griffiths and Marjoram, 1996; Song and Hein, 2005) . The advantage of the ARG approach is of course that there is an underlying population genetic model, which HINT lacks. Comparing the performance of the two approaches is an interesting research direction.
We have focused our attention here on human genotypes. Haplotype inference and association testing is being applied to other organisms, where the levels of variability and of recombination may be quite different. While HINT can be applied to any organism, performance may not be as good on some organisms. In such cases, retuning of HINT may be necessary, and other approaches that exploit the properties of these organisms' haplotypes may be better.
Another natural extension that we intend to pursue is to include the pedigree information, when available (e.g., HapMap and ENCODE trios), to the HINT inference. Such extension would have a clear advantage by combining the population LD data as HINT does with the transmission information from the trios. (We have already implemented a similar extension for the GERBIL model.)
In our simulation for disease prediction, we assumed for simplicity that the disease trait has 100% penetrance and that it is caused by a single SNP. Obviously, under such assumptions, the trait would be a Mendelian factor and would be mapped by linkage much faster and more easily than by a population association test. None of the diseases that are being mapped by association testing today have such major SNPs, but instead entail multiple SNPs with weak penetrance. Extending the simulation to these more complex and more realistic scenarios is therefore desirable, but it would require substantially larger population sizes.
In this study, our focus was to build a model with improved performance in association studies. We did not aim to improve the phasing per se, and therefore we did not compare phasing quality to that of extant phasing programs. If one wishes to use HINT for phasing, a natural question is how to assign confidence to individual haplotypes or to a phased pair of haplotypes. Naturally, the HMM attributes a probability to each pair of paths it produces. To distinguish among near-optimal solutions, one should find several best-scoring path pairs for each genotype and compare their probabilities. Another criterion for phasing performance is a direct comparison to a known solution, using, e.g., the switch test (Stephens and Donnelly, 2003; Kimmel and Shamir, 2005) or error rate (Stephens and Donnelly, 2003; . Note that when phasing a large number of SNPs, the resulting pairs of full haplotypes are less meaningful for association, as most of the SNPs are relatively distant from each other and thus poorly associated. A better definition of phasing and haplotypes that emphasizes locality is needed in these cases.
